Comparison between Earum Pharmaceuticals IPO and Gensol Engineering IPO.
Earum Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Gensol Engineering IPO is a SME Bookbuilding proposed to list at BSE SME.
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Hem Securities Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Hem Securities Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Gensol Engineering IPO is up to ₹17.02 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Gensol Engineering IPO is ₹83.00 per share.
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹81.00 per share | |
| Issue Price (Upper) | ₹83.00 per share | |
| Issue Price (Final) | ₹36.00 per share | ₹83.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 17,52,000 shares | 20,51,200 shares |
| Fresh Issue Size (Amount) | up to ₹6.31 Cr | up to ₹17.02 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,52,000 shares | 20,51,200 shares |
| Issue Size Total (Amount) | up to ₹6.31 Cr | up to ₹17.02 Cr |
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Gensol Engineering IPO opens on Sep 30, 2019. The closing date of Earum Pharmaceuticals IPO and Gensol Engineering IPO is Jun 26, 2019, and Oct 04, 2019, respectively.
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 21, 2019 | Sep 30, 2019 |
| Issue Close | Jun 26, 2019 | Oct 04, 2019 |
| Basis Of Allotment (Tentative) | Jul 01, 2019 | Oct 10, 2019 |
| Initiation of Refunds (Tentative) | Jul 02, 2019 | Oct 11, 2019 |
| Credit of Share (Tentative) | Jul 03, 2019 | Oct 14, 2019 |
| Listing date (Tentative) | Jul 04, 2019 | Oct 15, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Earum Pharmaceuticals IPO P/E ratio is , as compared to Gensol Engineering IPO P/E ratio of .
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 96 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.04 | 70.72 | ||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Gensol Engineering IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Gensol Engineering IPO.
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 96,000 shares | 1,08,800 shares |
| QIB | ||
| NII | 8,76,000 shares | 10,25,600 shares |
| RII | 8,76,000 shares | 10,25,600 shares |
| Employee | ||
| Others | ||
| Total | 17,52,000 shares | 20,51,200 shares |
Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas Gensol Engineering IPO subscribed 1.32x.
| Earum Pharmaceuticals IPO | Gensol Engineering IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.72x | 2.27x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.48x | 0.37x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.60x | 1.32x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
